Home LiteratureArticle Details
PMID: 4885615 Published · ppublish English Clinical Trial Journal Article Randomized Controlled Trial

Controlled trial of dipyridamole in cerebral vascular disease.

British medical journal ·Vol. 1 ·No. 5644 ·1969-03-08 ·Pages 614-5

Acheson J, Danta G, Hutchinson EC

Abstract

A controlled double-blind study of the effect of dipyridamole was performed in 169 patients with established cerebral vascular disease. A dose of 400 mg. was used initially, given daily for an average of 14 months; the dose was then increased to 800 mg. daily for a further average period of 11 months. When the incidence of cerebral ischaemic episodes during treatment was compared in the drug-treated and placebo-treated groups no significant difference was found.

MeSH Terms
Cerebrovascular Disorders/drug therapy Clinical Trials as Topic Dipyridamole/administration & dosage,adverse effects,therapeutic use Female Headache/chemically induced Humans Ischemic Attack, Transient/drug therapy Kidney Function Tests Liver Function Tests Male Middle Aged
Chemicals
Dipyridamole
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Acheson J
Danta G
Hutchinson E C
References (18)
18 references, click to expand
  1. Dipyridamole in the treatment of angina pectoris. A double-blind evaluation.
    JAMA. 1967 Sep 11;201(11):865-7 PMID: 5340622
  2. LONG TERM DIPYRIDAMOLE THERAPY OF ANGINA PECTORIS.
    Am J Cardiol. 1965 Aug;16:234-7 PMID: 14340823
  3. Evaluation of dipyridamole (Persantin).
    Am Heart J. 1963 Mar;65:423-4 PMID: 14026460
  4. AUGMENTATION OF INTERCORONARY ANASTOMOSIS BY LONG-TERM ADMINISTRATION OF A VASODILATOR DRUG, DIPYRIDAMOLE (PERSANTIN).
    Can Med Assoc J. 1964 Apr 18;90:970-3 PMID: 14139998
  5. PERSANTIN-- A DOUBLE BLIND STUDY.
    Angiology. 1964 Jun;15:290-2 PMID: 14170587
  6. A controlled clinical trial of 'persantin' (R A 8) in angina pectoris.
    S Afr Med J. 1961 Jan 7;35:11-3 PMID: 13788617
  7. Reduction of platelet adhesiveness in patients with coronary artery disease.
    Am J Med Sci. 1968 May;255:292-5 PMID: 5650752
  8. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report.
    N Engl J Med. 1968 Sep 12;279(11):576-80 PMID: 5667468
  9. Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit.
    Nature. 1965 Oct 16;208(5007):255-7 PMID: 5882451
  10. [The effect of Persantin on heart muscle sarcosomes].
    Experientia. 1961 Sep 15;17:415-6 PMID: 14462727
  11. Controlled double-blind trial of "persantin" in treatment of angina pectoris.
    Br Med J. 1960 Sep 17;2(5202):835 PMID: 13824151
  12. Effect of dipyridamole on human platelet behaviour.
    Lancet. 1965 Sep 25;2(7413):603-6 PMID: 4157500
  13. The effect of persantin on intercoronary collateral circulation and survival during gradual experimental coronary occlusion. A preliminary report.
    Can Med Assoc J. 1962 Aug 18;87:336-45 PMID: 13926101
  14. [Function and energy metabolism of the exhausted heart muscle under the effects of 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)-pyrimidine].
    Arzneimittelforschung. 1962 Jul;12:683-91 PMID: 13912692
  15. Enhancement of coronary vasodilator action of adenosine triphosphate by dipyridamole.
    Circ Res. 1967 Apr;20(4):403-8 PMID: 6025404
  16. Experimental and clinical observations on 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d) pyrimidine (Persantin).
    Am J Med Sci. 1962 Jun;243:783-9 PMID: 13914979
  17. [Pharmacologically-induced development of coronary collaterals in relation to dosage].
    Arzneimittelforschung. 1966 Apr;16(4):501-9 PMID: 6014261
  18. EXPERIMENTAL STUDIES ON THE EFFECTS OF PERSANTIN WITH NORMAL AND GO-DOGS.
    Bull Osaka Med Sch. 1963 Apr;9:106-28 PMID: 14152245
Article Info
Journal
British medical journal
Abbr.
Br Med J
ISSN
0007-1447
DOI
10.1136/bmj.1.5644.614
Published
1969-03-08
Pages
614-5
Language
English
Region
England
NLM ID
0372673
PMCID
PMC1982429
Subset
IM
External Links
PubMed source DOI: 10.1136/bmj.1.5644.614 PMC Full Text
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2